BeiGene, Ltd. (NASDAQ:BGNE) is a Massachusetts-based biotechnology company that focuses on discovering, developing, and commercializing medicines worldwide.
The market for community oncology services worldwide is projected to experience substantial growth, with an estimated increase from $47.95 billion in 2022 to $53.79 billion in 2023, indicating a compound.